Impact of postoperative complications on overall survival of patients with hepatoblastoma

Pediatric Blood and Cancer

Volumn 62, Issue 1, 2015, Pages 24-28

  Becker, Kristina ^a   Furch, Christiane ^a   Schmid, Irene ^a   von Schweinitz, Dietrich ^a   Häberle, Beate ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Hepatoblastoma (HB); High risk (HR) group; Postoperative complications; Tumor resection; Vessel involvement

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE;

ACUTE LIVER FAILURE; ADULT; AIR EMBOLISM; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BILE LEAKAGE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHOLESTASIS; DIAPHRAGM EVENTRATION; DRUG MEGADOSE; FEMALE; GERMANY; HEART ARREST; HEPATOBLASTOMA; HIGH RISK PATIENT; HUMAN; INTESTINE OBSTRUCTION; LIVER PERFUSION; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER VEIN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; MULTICENTER STUDY; OPERATIVE BLOOD LOSS; OVERALL SURVIVAL; PEROPERATIVE COMPLICATION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; SURVIVAL RATE; SURVIVAL TIME; TUMOR VASCULARIZATION; TUMOR VOLUME; VEIN INJURY; ADOLESCENT; CHILD; CLINICAL TRIAL; FOLLOW UP; INFANT; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPH NODE METASTASIS; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; SECONDARY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATOBLASTOMA; HUMANS; INFANT; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84922764084     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25240     Document Type: Article

References (25)

1. Fuchs J, Rydzynski J, Von Schweinitz D, et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: A report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 2002; 95:172-182.
2. Pritchard J, Brown J, Shafford E, et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: A successful approach-Results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol 2000; 18:3819-3828.
3. Haberle B, Bode U, von Schweinitz D. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma-An interim report of the German Liver Tumor Study HB99]. Klin Padiatr 2003; 215:159-165.
4. Ortega JA, Douglass EC, Feusner JH, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 2000; 18:2665-2675.
5. Schnater JM, Kohler SE, Lamers WH, et al. Where do we stand with hepatoblastoma? A review. Cancer 2003; 98:668-678.
6. Perilongo G, Shafford EA. Liver tumours. Eur J Cancer 1999; 35:953-958 ; discussion 958-959.
7. Finegold MJ. Chemotherapy for suspected hepatoblastoma without efforts at surgical resection is a bad practice. Med Pediatr Oncol 2002; 39:484-486.
8. Czauderna P, Otte JB, Roebuck DJ, et al. Surgical treatment of hepatoblastoma in children. Pediatr Radiol 2006; 36:187-191.
9. Perilongo G, Malogolowkin M, Feusner J. Hepatoblastoma clinical research: Lessons learned and future challenges. Pediatr Blood Cancer 2012; 59:818-821.
10. Brown J, Perilongo G, Shafford E, et al. Pretreatment prognostic factors for children with hepatoblastoma-Results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 2000; 36:1418-1425.
11. Tannuri AC, Tannuri U, Gibelli NE, et al. Surgical treatment of hepatic tumors in children: Lessons learned from liver transplantation. J Pediatr Surg 2009; 44:2083-2087.
12. Pham TH, Iqbal CW, Grams JM, et al. Outcomes of primary liver cancer in children: An appraisal of experience. J Pediatr Surg 2007; 42:834-839.
13. Fuchs J, Rydzynski J, Hecker H, et al. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma-A report from the German Cooperative Liver Tumour Studies HB 89 and HB 94. Eur J Pediatr Surg 2002; 12:255-261.
14. von Schweinitz D, Burger D, Mildenberger H. Is laparatomy the first step in treatment of childhood liver tumors?-The experience from the German Cooperative Pediatric Liver Tumor Study HB-89. Eur J Pediatr Sur 1994; 4:82-86.
15. Haeberle B, Schweinitz D. Treatment of hepatoblastoma in the German cooperative pediatric liver tumor studies. Front Biosci (Elite Ed) 2012; 4:493-498.
16. Roebuck DJ, Aronson D, Clapuyt P, et al. PRETEXT: A revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 2007 2005; 37:123-132 ; quiz 249-150.
17. Schnater JM, Aronson DC, Plaschkes J, et al. Surgical view of the treatment of patients with hepatoblastoma: Results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 2002; 94:1111-1120.
18. Superina RA, Bambini D, Filler RM, et al. A new technique for resecting 'unresectable' liver tumors. J Pediatr Surg 2000; 35:1294-1299.
19. von Schweinitz D, Faundez A, Teichmann B, et al. Hepatocyte growth-factor-scatter factor can stimulate post-operative tumor-cell proliferation in childhood hepatoblastoma. Int J Cancer 2000; 85:151-159.
20. von Schweinitz D, Fuchs J, Gluer S, et al. The occurrence of liver growth factor in hepatoblastoma. Eur J Pediatr Surg 1998; 8:133-136.
21. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276:60-66.
22. Grotegut S, von Schweinitz D, Christofori G, et al. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 2006; 25:3534-3545.
23. Grotegut S, Kappler R, Tarimoradi S, et al. Hepatocyte growth factor protects hepatoblastoma cells from chemotherapy-induced apoptosis by AKT activation. Int J Oncol 2010; 36:1261-1267.
24. Otte JB. Progress in the surgical treatment of malignant liver tumors in children. Cancer Treat Rev 2010; 36:360-371.
25. Millar AJ, Hartley P, Khan D, et al. Extended hepatic resection with transplantation back-up for an "unresectable" tumour. Pediatr Surg Int 2001; 17:378-381.